SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-04-005312
Filing Date
2004-02-23
Accepted
2004-02-23 16:50:09
Documents
4
Period of Report
2004-02-13
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2129403z8-k.txt 8-K 4206
3 EXHIBIT 1.1 a2129403zex-1_1.txt EX-1.1 79484
4 EXHIBIT 1.2 a2129403zex-1_2.txt EX-1.2 4205
5 EXHIBIT 99.1 a2129403zex-99_1.txt EX-99.1 6682
  Complete submission text file 0001047469-04-005312.txt   96580
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 04622471
SIC: 2835 In Vitro & In Vivo Diagnostic Substances